GlassScriptPhysician profile
Kurt M Jacobson
NPI 1518947712
$24,400.64
in general payments reported to CMS, 2019-2025
7 companies · $90.20 in 2025
The $90.20 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $7,369 · 2021: $1,302 · 2023: $77.41 · 2024: $900 · 2025: $90.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $811 · Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $811.11 |
| Food and Beverage | $256.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $21,431.57 | 2019-2020 | |
| Boston Scientific Corporation | $811.11 | 2024 | |
| Edwards Lifesciences Corporation | $669.39 | 2021 | |
| W. L. Gore & Associates, INC. | $600.00 | 2019 | |
| Angiodynamics, INC. | $470.58 | 2021 | |
| Medtronic, INC. | $327.79 | 2021-2024 | Corevalve Evolut R |
| Abbott Laboratories | $90.20 | 2025 | Mitraclip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Jacobson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.